Sugi Predict

Sugi Predict / Compounds / SCHEMBL513121

SCHEMBL513121

SCHEMBL513121

O[C@H]1Cc2c(OCc3ccccc3)cc(OCc3ccccc3)cc2O[C@@H]1c1cc(OCc2ccccc2)c(OCc2ccccc2)c(OCc2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.52
▸ STING1 Q86WV6 1/20 0.51
▸ CYP3A4 P08684 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ PTGS1 P23219 4/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ MAOB P27338 4/20 0.40
▸ MAOA P21397 2/20 0.40
▸ SYNJ2 O15056 2/20 0.39
▸ BACE1 P56817 2/20 0.39
▸ SNCA P37840 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ APEX1 P27695 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24983403 1.00 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL30892442 1.00 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL30141015 1.00 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL513122 1.00 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL513123 1.00 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL30141115 0.95 ABCB1 (0.61) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL24983863 0.95 ABCB1 (0.61) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL21588103 0.94 ABCB1 (0.51) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL23202784 0.92 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1
SCHEMBL30350408 0.92 ABCB1 (0.52) ABCB1STING1CYP3A4MAPK1PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9399631-B2 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2016-07-26 — — US disclosed
US-20160068503-A1 (-)-EPIGALLOCATECHIN GALLATE DERIVATIVES FOR INHIBITING PROTEASOME THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2016-03-10 — — US disclosed
US-9169230-B2 (−)-Epigallocatechin gallate derivatives for inhibiting proteasome THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2015-10-27 — — US disclosed
US-20140213802-A1 (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2014-07-31 — — US disclosed
US-8710248-B2 (−)-epigallocatechin gallate derivatives for inhibiting proteasome THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2014-04-29 — — US disclosed
US-20140045931-A1 POLYPHENOL PROTEASOME INHIBITORS, SYNTHESIS, AND METHODS OF USE THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2014-02-13 — — US disclosed
US-8563607-B2 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2013-10-22 — — US disclosed
US-20120232135-A1 (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2012-09-13 — — US disclosed
US-8193377-B2 (−)-epigallocatechin gallate derivatives for inhibiting proteasome THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2012-06-05 — — US disclosed
US-20120029067-A1 Polyphenol Proteasome Inhibitors, Synthesis, and Methods of Use UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-02 — — US disclosed
US-20100173985-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2010-07-08 — — US disclosed
US-20100173985-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2010-07-08 — — US disclosed
US-7544816-B2 (−)-Epigallocatechin gallate derivatives for inhibiting proteasome THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2009-06-09 — — US disclosed
US-20080176931-A1 e.g. 5,7-Bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3-(benzyloxy)benzoate; antiproliferative, antitumor agent; reducing tumor cell growth; more potent, better bioavailability than catechin THE HONG KONG POLYTECHNIC UNIVERSITY (HK) 2008-07-24 — — US disclosed
US-7358383-B2 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2008-04-15 — — US disclosed
US-7358383-B2 Polyphenol proteasome inhibitors, synthesis, and methods of use UNIVERSITY OF SOUTH FLORIDA (US) 2008-04-15 — — US disclosed
US-20080015248-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use DOU Q P 2008-01-17 — — US disclosed
US-20080015248-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use DOU Q P 2008-01-17 — — US disclosed
US-20060041010-A1 5,7-Bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3-(benzyloxy)benzoate; antiproliferative, antitumor agent; reducing tumor cell growth; more potent, better bioavailability than catechin THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2006-02-23 — — US disclosed
US-20040186167-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2004-09-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140045931-A1 POLYPHENOL PROTEASOME INHIBITORS, SYNTHESIS, AND METHODS OF USE PSMC1, PSMB5, PSMC5 ABCB1 2639/4885STING1 3665/4885CYP3A4 2344/4885
US-20120232135-A1 (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome PSMC1, PSME1, PSMB1 ABCB1 2548/4885STING1 3254/4885CYP3A4 3777/4885
US-20060041010-A1 5,7-Bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3-(benzyloxy)benzoate; antiproliferative, antitumor agent; reducing tumor cell growth; more potent, better bioavailability than catechin PSMB10, PSMC1, PSMD10 ABCB1 916/4885STING1 3257/4885CYP3A4 788/4885
US-20080015248-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use PSMC1, PSMB5, PSMC5 ABCB1 2639/4885STING1 3665/4885CYP3A4 2344/4885
US-20160068503-A1 (-)-EPIGALLOCATECHIN GALLATE DERIVATIVES FOR INHIBITING PROTEASOME PSMC1, PSME1, PSMB1 ABCB1 2548/4885STING1 3254/4885CYP3A4 3777/4885
US-20100173985-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use PSMC1, PSMB5, PSMC5 ABCB1 2639/4885STING1 3665/4885CYP3A4 2344/4885
US-20120029067-A1 Polyphenol Proteasome Inhibitors, Synthesis, and Methods of Use PSMC1, PSMB5, PSMC5 ABCB1 2639/4885STING1 3665/4885CYP3A4 2344/4885
US-20040186167-A1 Polyphenol proteasome inhibitors, synthesis, and methods of use PSMC1, PSMB5, PSMC5 ABCB1 2639/4885STING1 3665/4885CYP3A4 2344/4885
US-20140213802-A1 (-)-Epigallocatechin Gallate Derivatives for Inhibiting Proteasome PSMC1, PSME1, PSMB1 ABCB1 2548/4885STING1 3254/4885CYP3A4 3777/4885
US-20080176931-A1 e.g. 5,7-Bis(benzyloxy)-2-[3,4,5-tris(benzyloxy)phenyl]chroman-3-yl 3-(benzyloxy)benzoate; antiproliferative, antitumor agent; reducing tumor cell growth; more potent, better bioavailability than catechin UBE2G2, C9, BAP1 ABCB1 1438/4885STING1 3187/4885CYP3A4 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback